[1] Lucky S S, Soo K C, Zhang Y. Nanoparticles in photodynamic therapy[J]. Chemical Reviews, 115, 1990-2042(2015).

[2] Dougherty T J, Grindey G B, Fiel R et al. Photoradiation therapy. Ⅱ. cure of animal tumors with hematoporphyrin and light[J]. JNCI: Journal of the National Cancer Institute, 55, 115-121(1975).

[3] Chilakamarthi U, Giribabu L. Photodynamic therapy: past, present and future[J]. Chemical Record, 17, 775-802(2017).

[4] Du B J, Tung C H. Enzyme-assisted photodynamic therapy based on nanomaterials[J]. ACS Biomaterials Science & Engineering, 6, 2506-2517(2020).

[5] Griffin L L, Lear J T. Photodynamic therapy and non-melanoma skin cancer[J]. Cancers, 8, 98(2016).

[6] Kennedy J C, Marcus S L, Pottier R H. Photodynamic Therapy (PDT) and Photodiagnosis (PD) using endogenous photosensitization induced by 5-Aminolevulinic Acid (ALA): mechanisms and clinical results[J]. Journal of Clinical Laser Medicine & Surgery, 14, 289-304(1996).

[7] Choi S H, Kim K H, Song K H. Efficacy of ablative fractional laser-assisted photodynamic therapy with short-incubation time for the treatment of facial and scalp actinic keratosis: 12-month follow-up results of a randomized, prospective, comparative trial[J]. Journal of the European Academy of Dermatology and Venereology: JEADV, 29, 1598-1605(2015).

[8] Lan M H, Zhao S J, Liu W M et al. Photosensitizers for photodynamic therapy[J]. Advanced Healthcare Materials, 8, e1900132(2019).

[9] Babes A, Sauer S K, Moparthi L et al. Photosensitization in porphyrias and photodynamic therapy involves TRPA1 and TRPV1[J]. The Journal of Neuroscience, 36, 5264-5278(2016).

[10] Falk-Mahapatra R, Gollnick S O. Photodynamic therapy and immunity: an update[J]. Photochemistry and Photobiology, 96, 550-559(2020).

[11] Gwak Y S, Hassler S E, Hulsebosch C E. Reactive oxygen species contribute to neuropathic pain and locomotor dysfunction via activation of CamKII in remote segments following spinal cord contusion injury in rats[J]. Pain, 154, 1699-1708(2013).

[12] Wright L, Baptista-Hon D, Bull F et al. Menthol reduces phototoxicity pain in a mouse model of photodynamic therapy[J]. Pain, 159, 284-297(2018).

[13] Yoo J A, Yu E, Park S H et al. Blue light irradiation induces human keratinocyte cell damage via transient receptor potential vanilloid 1 (TRPV1) regulation[J]. Oxidative Medicine and Cellular Longevity, 2020, 8871745(2020).

[14] Jin F Y, Shi W D. New advances in the management of photodynamic therapy-associated pain[J]. The Chinese Journal of Dermatovenereology, 33, 1429-1432(2019).

[15] Julius D, Basbaum A I. Molecular mechanisms of nociception[J]. Nature, 413, 203-210(2001).

[16] Stucky C L, Gold M S, Zhang X. Mechanisms of pain[J]. Proceedings of the National Academy of Sciences of the United States of America, 98, 11845-11846(2001).

[17] Julius D. TRP channels and pain[J]. Annual Review of Cell and Developmental Biology, 29, 355-384(2013).

[18] Burgess P R, Perl E R. Myelinated afferent fibres responding specifically to noxious stimulation of the skin[J]. The Journal of Physiology, 190, 541-562(1967).

[19] Woolf C J, Salter M W. Neuronal plasticity: increasing the gain in pain[J]. Science, 288, 1765-1769(2000).

[20] Liao M F, Cao E H, Julius D et al. Structure of the TRPV1 ion channel determined by electron cryo-microscopy[J]. Nature, 504, 107-112(2013).

[21] Caterina M J, Schumacher M A, Tominaga M et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway[J]. Nature, 389, 816-824(1997).

[22] Vandewauw I, De Clercq K, Mulier M et al. A TRP channel trio mediates acute noxious heat sensing[J]. Nature, 555, 662-666(2018).

[23] Tominaga M, Caterina M J, Malmberg A B et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli[J]. Neuron, 21, 531-543(1998).

[24] Xu H X, Blair N T, Clapham D E. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism[J]. The Journal of Neuroscience, 25, 8924-8937(2005).

[25] Szallasi A, Blumberg P M. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper[J]. Neuroscience, 30, 515-520(1989).

[26] Sikand P, Premkumar L S. Potentiation of glutamatergic synaptic transmission by protein kinase C-mediated sensitization of TRPV1 at the first sensory synapse[J]. The Journal of Physiology, 581, 631-647(2007).

[27] Sugiura T, Tominaga M, Katsuya H et al. Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1[J]. Journal of Neurophysiology, 88, 544-548(2002).

[28] Zhang X M, Huang J H, McNaughton P A. NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels[J]. The EMBO Journal, 24, 4211-4223(2005).

[29] Denda M, Fuziwara S, Inoue K et al. Immunoreactivity of VR1 on epidermal keratinocyte of human skin[J]. Biochemical and Biophysical Research Communications, 285, 1250-1252(2001).

[30] Gouin O, L’Herondelle K, Lebonvallet N et al. TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization[J]. Protein & Cell, 8, 644-661(2017).

[31] Luo Y H, Suttle A, Zhang Q J et al. Transient receptor potential (TRP) ion channels in orofacial pain[J]. Molecular Neurobiology, 58, 2836-2850(2021).

[32] Fernandes E S, Fernandes M A, Keeble J E. The functions of TRPA1 and TRPV1: moving away from sensory nerves[J]. British Journal of Pharmacology, 166, 510-521(2012).

[33] Carbone E. Noradrenergic inhibition of presynaptic TRPV1 channels: a new pathway of pain control[J]. The Journal of Physiology, 595, 2413-2414(2017).

[34] Pinho-Ribeiro F A, Verri W A,, Chiu I M. Nociceptor sensory neuron-immune interactions in pain and inflammation[J]. Trends in Immunology, 38, 5-19(2017).

[35] Bautista D M, Jordt S E, Nikai T et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents[J]. Cell, 124, 1269-1282(2006).

[36] Bessac B F, Jordt S E. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control[J]. Physiology, 23, 360-370(2008).

[37] Caceres A I, Brackmann M, Elia M D et al. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma[J]. Proceedings of the National Academy of Sciences of the United States of America, 106, 9099-9104(2009).

[38] Sawada Y, Hosokawa H, Matsumura K et al. Activation of transient receptor potential ankyrin 1 by hydrogen peroxide[J]. The European Journal of Neuroscience, 27, 1131-1142(2008).

[39] Hill K, Schaefer M. Ultraviolet light and photosensitising agents activate TRPA1 via generation of oxidative stress[J]. Cell Calcium, 45, 155-164(2009).

[40] Ichikawa H, Sugimoto T. VR1-immunoreactive primary sensory neurons in the rat trigeminal ganglion[J]. Brain Research, 890, 184-188(2001).

[41] Gao X, Kim H K, Chung J M et al. Reactive oxygen species (ROS) are involved in enhancement of NMDA-receptor phosphorylation in animal models of pain[J]. Pain, 131, 262-271(2007).

[42] Yowtak J, Lee K Y, Kim H Y et al. Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release[J]. Pain, 152, 844-852(2011).

[43] Lee D Z, Chung J M, Chung K et al. Reactive oxygen species (ROS) modulate AMPA receptor phosphorylation and cell-surface localization in concert with pain-related behavior[J]. Pain, 153, 1905-1915(2012).

[44] Borgia F, Giuffrida R, Caradonna E et al. Early and late onset side effects of photodynamic therapy[J]. Biomedicines, 6, 12(2018).

[45] Wiegell S R, Haedersdal M, Wulf H C. Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study[J]. Acta Dermato-Venereologica, 89, 145-149(2009).

[46] Ericson M B, Sandberg C, Stenquist B et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome[J]. British Journal of Dermatology, 151, 1204-1212(2004).

[47] Ibbotson S H, Wong T H, Morton C A et al. Adverse effects of topical photodynamic therapy: a consensus review and approach to management[J]. British Journal of Dermatology, 180, 715-729(2019).

[48] Alzeibak R, Mishchenko T A, Shilyagina N Y et al. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future[J]. Journal for Immunotherapy of Cancer, 9, e001926(2021).

[49] Cecic I, Korbelik M. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors[J]. Cancer Letters, 183, 43-51(2002).

[50] Dougherty T J, Gomer C J, Henderson B W et al. Photodynamic therapy[J]. JNCI: Journal of the National Cancer Institute, 90, 889-905(1998).

[51] Gollnick S O, Evans S S, Baumann H et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation[J]. British Journal of Cancer, 88, 1772-1779(2003).

[52] Cecic I, Sun J H, Korbelik M. Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells[J]. Photochemistry and Photobiology, 82, 558-562(2006).

[53] Brackett C M, Muhitch J B, Evans S S et al. IL-17 promotes neutrophil entry into tumor-draining lymph nodes following induction of sterile inflammation[J]. Journal of Immunology, 191, 4348-4357(2013).

[54] Korbelik M, Sun J H, Cecic I. Photodynamic therapy–induced cell surface expression and release of heat shock proteins: relevance for tumor response[J]. Cancer Research, 65, 1018-1026(2005).

[55] Reeve A J, Patel S, Fox A et al. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat[J]. European Journal of Pain, 4, 247-257(2000).

[56] Jin H M, Wang Q Q, Wu J W et al. Baicalein inhibits the IL-1β- induced inflammatory response in nucleus pulposus cells and attenuates disc degeneration in vivo[J]. Inflammation, 42, 1032-1044(2019).

[57] Jia J L, Nie L, Liu Y. Butyrate alleviates inflammatory response and NF-κB activation in human degenerated intervertebral disc tissues[J]. International Immunopharmacology, 78, 106004(2020).

[58] Omote K, Hazama K, Kawamata T et al. Peripheral nitric oxide in carrageenan-induced inflammation[J]. Brain Research, 912, 171-175(2001).

[59] Tsuchida K, Ibuki T, Matsumura K. Bromoenol lactone, an inhibitor of calcium-independent phospholipase A2, suppresses carrageenan-induced prostaglandin production and hyperalgesia in rat hind paw[J]. Mediators of Inflammation, 2015, 605727(2015).

[60] Moriyama T, Higashi T, Togashi K et al. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins[J]. Molecular Pain, 1, 1744-8069(2005).

[61] Studer R K, Vo N, Sowa G et al. Human nucleus pulposus cells react to IL-6: independent actions and amplification of response to IL-1 and TNF-α[J]. Spine, 36, 593-599(2011).

[62] George A, Schmidt C, Weishaupt A et al. Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury[J]. Experimental Neurology, 160, 124-132(1999).

[63] Schäfers M, Geis C, Svensson C I et al. Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve[J]. The European Journal of Neuroscience, 17, 791-804(2003).

[64] Bennett G J. A neuroimmune interaction in painful peripheral neuropathy[J]. The Clinical Journal of Pain, 16, S139-S143(2000).

[65] George A, Buehl A, Sommer C. Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve[J]. Experimental Neurology, 192, 163-166(2005).

[66] Schäfers M, Svensson C I, Sommer C et al. Tumor necrosis factor-α induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons[J]. The Journal of Neuroscience, 23, 2517-2521(2003).

[67] Shu X Q, Mendell L M. Neurotrophins and hyperalgesia[J]. Proceedings of the National Academy of Sciences of the United States of America, 96, 7693-7696(1999).

[68] Zhang J H, Huang Y G. The immune system: a new look at pain[J]. Chinese Medical Journal, 119, 930-938(2006).

[69] Kajihara Y, Murakami M, Imagawa T et al. Histamine potentiates acid-induced responses mediating transient receptor potential V1 in mouse primary sensory neurons[J]. Neuroscience, 166, 292-304(2010).

[70] Ramírez-García P D, Retamal J S, Shenoy P et al. A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain[J]. Nature Nanotechnology, 14, 1150-1159(2019).

[71] Jensen D D, Lieu T, Halls M L et al. Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief[J]. Science Translational Medicine, 9, eaal3447(2017).

[72] Negri S, Faris P, Tullii G et al. Conjugated polymers mediate intracellular Ca2+ signals in circulating endothelial colony forming cells through the reactive oxygen species-dependent activation of Transient Receptor Potential Vanilloid 1 (TRPV1)[J]. Cell Calcium, 101, 102502(2022).

[73] Ang J M, Riaz I B, Kamal M U et al. Photodynamic therapy and pain: a systematic review[J]. Photodiagnosis and Photodynamic Therapy, 19, 308-344(2017).

[74] Hambly R A, Mansoor N, Quinlan C et al. Factors predicting pain and effect of oral analgesia in topical photodynamic therapy[J]. Photodermatology, Photoimmunology & Photomedicine, 33, 176-179(2017).

[75] Miller I M, Nielsen J S, Lophaven S et al. Factors related to pain during routine photodynamic therapy: a descriptive study of 301 patients[J]. Journal of the European Academy of Dermatology and Venereology: JEADV, 25, 1275-1281(2011).

[76] Zhou J, Liu J, Hu D et al. Analgesic effect of flurbiprofen ester in hematoporphyrin monomethyl ether-mediated photodynamic therapy for port-wine stains: preliminary clinical observations[J]. The Chinese Journal of Dermatovenereology, 34, 534-537(2020).

[77] Borelli C, Herzinger T, Merk K et al. Effect of subcutaneous infiltration anesthesia on pain in photodynamic therapy: a controlled open pilot trial[J]. Dermatologic Surgery, 33, 314-318(2007).

[78] Chaves Y N, Torezan L A, Niwa A B M et al. Pain in photodynamic therapy: mechanism of action and management strategies[J]. Anais Brasileiros De Dermatologia, 87, 521-529(2012).

[79] Klein A, Karrer S, Horner C et al. Comparing cold-air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial[J]. British Journal of Dermatology, 173, 192-200(2015).

[80] Skiveren J, Haedersdal M, Philipsen P A et al. Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study[J]. Acta Dermato-Venereologica, 86, 409-411(2006).

[81] Liu L, Zhang Z H, Jiang X. Assessment of the analgesic effect of compound lidocaine cream in patients with port-wine stain treated by hemoporfin photodynamic therapy[J]. Proceedings of SPIE, 11070, 110707G(2019).

[82] Holmes M V, Dawe R S, Ferguson J et al. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (AmetopR) for pain relief during topical photodynamic therapy[J]. British Journal of Dermatology, 150, 337-340(2004).

[83] Anseline W, Grose D, Smith P et al. A plant-derived anti-nociceptive spray for reduction of pain with photodynamic therapy[J]. Photodiagnosis and Photodynamic Therapy, 11, 467-471(2014).

[84] Cabete J, Campos S, Lestre S. Conscious sedation with inhaled 50% nitrous oxide/oxygen premix in photodynamic therapy sessions for vulvar lichen sclerosus treatment[J]. Anais Brasileiros De Dermatologia, 90, 120-122(2015).

[85] Fink C, Uhlmann L, Enk A et al. Pain management in photodynamic therapy using a nitrous oxide/oxygen mixture: a prospective, within-patient, controlled clinical trial[J]. Journal of the European Academy of Dermatology and Venereology: JEADV, 31, 70-74(2017).

[86] Raulin C, Greve B, Hammes S. Cold air in laser therapy: first experiences with a new cooling system[J]. Lasers in Surgery and Medicine, 27, 404-410(2000).

[87] Pagliaro J, Elliott T, Bulsara M et al. Cold air analgesia in photodynamic therapy of basal cell carcinomas and Bowen’s disease: an effective addition to treatment: a pilot study[J]. Dermatologic Surgery, 30, 63-66(2004).

[88] Wennberg A M. Pain, pain relief and other practical issues in photodynamic therapy[J]. The Australasian Journal of Dermatology, 46, S3-S4(2005).

[89] Osiecka B J, Nockowski P, Szepietowski J C. Treatment of actinic keratosis with photodynamic therapy using red or green light: a comparative study[J]. Acta Dermato-Venereologica, 98, 689-693(2018).

[90] Zeitouni N C, Paquette A D, Housel J P et al. A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer[J]. Lasers in Surgery and Medicine, 45, 89-94(2013).

[91] Wiegell S R, Haedersdal M, Philipsen P A et al. Continuous activation of PpⅨ by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study[J]. The British Journal of Dermatology, 158, 740-746(2008).

[92] Lin L, Li B H. Application progress of light-emitting diode for photodynamic therapy[J]. Laser & Optoelectronics Progress, 57, 150001(2020).

[93] Gholam P, Bosselmann I, Enk A H et al. Low irradiance compared with conventional photodynamic therapy in the treatment of actinic keratoses[J]. Photodermatology, Photoimmunology & Photomedicine, 35, 110-115(2019).

[94] Cottrell W J, Paquette A D, Keymel K R et al. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas[J]. Clinical Cancer Research, 14, 4475-4483(2008).

[95] Wulf H C. The background and philosophy behind daylight photodynamic therapy[J]. Giornale Italiano Di Dermatologia e Venereologia, 153, 776-782(2018).

[96] Nguyen M, Sandhu S S, Sivamani R K. Clinical utility of daylight photodynamic therapy in the treatment of actinic keratosis-a review of the literature[J]. Clinical, Cosmetic and Investigational Dermatology, 12, 427-435(2019).

[97] Wiegell S R, Wulf H C, Szeimies R M et al. Daylight photodynamic therapy for actinic keratosis: an international consensus[J]. Journal of the European Academy of Dermatology and Venereology: JEADV, 26, 673-679(2012).

[98] Fink C, Enk A, Gholam P. Photodynamic therapy-aspects of pain management[J]. JDDG: Journal Der Deutschen Dermatologischen Gesellschaft, 13, 15-22(2015).